Innovation1 Biotech (IVBT) Stock Price

Innovation1 Biotech Price

NYSE·CLOSED
0.00
​
Market closed

Revenue at Innovation1 Biotech has contracted by 43.1% per year over the past 3 years to 3,100.00 USD. Innovation1 Biotech's net margin stands at 33,545.2%, up from 5,806.5% several years earlier.

Innovation1 Biotech stock price

Access this data via the Eulerpool API

Innovation1 Biotech business model & stock analysis

Innovation1 Biotech, Inc. is a drug discovery company, which engages in the development of modified Schedule 1 molecules of botanical origin to create derivatives for treatment of neurologic, psychiatric, dermatologic, and ophthalmologic disorders. The company is headquartered in Rockaway, New Jersey. The company went IPO on 2017-02-06. The company has a portfolio of products using five preclinical prodrugs, all fully synthetic without connection to botanical sourcing: a mushroom-derived psychedelic molecule for treatment of post-traumatic stress disorder and depression, a cannabinoid and tree bark derived psychedelic for treatment of addiction and three additional cannabinoid prodrugs addressing clinical indications of refractory pediatric epilepsy, hypertrophic scarring, and ocular inflammation. The first agent is a prodrug of psilocin, a molecule naturally found in certain mushroom species. The second agent is a prodrug of synthetic tetrahydrocannobivarin, a molecule naturally found in Cannabis that modulates the two principal cannabinoid receptors: CBR1 and CBR2. The third agent is a prodrug of synthetic cannabidophorol.

Frequently asked questions about Innovation1 Biotech

Converted at the current exchange rate, the Innovation1 Biotech share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Innovation1 Biotech.

The profit cannot currently be calculated for Innovation1 Biotech.

The P/E ratio cannot be calculated for Innovation1 Biotech at the moment.

The P/S cannot be calculated for Innovation1 Biotech currently.

The Eulerpool Quality Score for Innovation1 Biotech is 2/10.

The ISIN of Innovation1 Biotech is US39809D2018. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Innovation1 Biotech is IVBT. The ticker symbol is used to trade Innovation1 Biotech shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Currency
USD
Initial public offering
Feb 6, 2017
ISIN
US39809D2018
Cusip
39809D201
Market capitalization
4,494.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
439.84 %
Last updated Oct 8, 2026, 11:42 AM

Innovation1 Biotech Peer Group

Innovation1 Biotech Ticker

OTC · GMVP

Innovation1 Biotech FIGI

IVBT:US · BBG008H3TJD0IVBT:PQ · BBG008H3V0P5IVBT:UV · BBG008H3V0Q4